Can Execution and Volume Trends Support DaVita's Q1 Earnings?
DVA's first-quarter 2026 results may face seasonal volume and RPT headwinds, but cost discipline, reimbursement growth and IKC contributions could aid results.
Zacks·1d ago
More News
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives Consensus Rating of "Moderate Buy" from Brokerages
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) has been given a consensus rating of "Moderate Buy" by the eleven brokerages that are covering the company, Marketbeat Ratings...
MarketBeat·4d ago
Chemed (CHE) Beats Q1 Earnings and Revenue Estimates
Chemed (CHE) delivered earnings and revenue surprises of +9.28% and +2.59%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·9d ago
Auna S.A.'s Oncology Initiatives Continue to Gain Traction in Mexico
AUNA advances oncology push in Mexico with new Oncocenter, insurer tie-ups, and rising revenues, signaling strong traction in a key growth market.
Zacks·15d ago
How Much Upside is Left in Aveanna (AVAH)? Wall Street Analysts Think 43.07%
The mean of analysts' price targets for Aveanna (AVAH) points to a 43.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·15d ago
Aveanna Healthcare (NASDAQ:AVAH) Price Target Cut to $8.00 by Analysts at Truist Financial
Truist Financial decreased their price target on Aveanna Healthcare from $9.00 to $8.00 and set a "hold" rating on the stock in a research note on Monday...
MarketBeat·19d ago
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eleven analysts that are currently covering the...
MarketBeat·29d ago
Is AUNA S.A. a Solid Investment Opportunity Post Q4 Earnings?
AUNA rallies after Q4 as Peru growth, Mexico recovery signals, and rising cash flow strengthen its outlook and balance sheet.
Zacks·1mo ago
Aveanna Healthcare (NASDAQ:AVAH) Price Target Lowered to $9.50 at Barclays
Barclays lowered their price objective on shares of Aveanna Healthcare from $11.00 to $9.50 and set an "overweight" rating for the company in a report on Wednesday...
MarketBeat·1mo ago
Aveanna Healthcare (NASDAQ:AVAH) Price Target Lowered to $9.00 at Royal Bank Of Canada
Royal Bank Of Canada decreased their target price on shares of Aveanna Healthcare from $11.00 to $9.00 and set a "sector perform" rating for the company in a report on Monday...